Drug giant Eli Lilly has announced a $35 (£30) cap on the monthly costs patients face for insulin in the US, responding to outcry over the soaring cost of the diabetes medication. More than eight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback